Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 1997

View Archived Issues

NIH seeks licensees for antispasmodic immunotoxin

Licenses offered for vasospasm therapy

NIH seeks licensees for method of treating allergies and HIV

Method of treating allergies and HIV offered for licensing

NIH seeks licensees for therapeutic/diagnostic HAV receptor

Antiviral nucleoside analogues available for licensing

CD40 ligands and MAbs offered for licensing

NIH seeks licensees for cancer vaccines

Licensees sought for recombinant laminin receptors

Transcriptional cofactor offered by NIH

DNA sequencing technology available for licensing

Medco's cardiovascular evaluation agent receives European approval

Correlation between asthma and IL-10

Gene vaccination shows potential against allergy

Phase I results with rhIL-4 receptor

Long-term use of recombinant IFN-gamma evaluated

Acorda and Elan to collaborate on spinal cord injury treatment

GalaGen's Diffistat-G advances through phase I

Role of IL-5 in asthma

IL-15 enhancement of neonatal defenses

Merck's Fosamax earns recommendation

Combination beta-agonist/corticosteroid therapy beneficial in asthma

Novo Nordisk's growth hormone now available in 67 countries

Efficacy of hydoxychloroquine in asthma

Review date set for Sonus ultrasound contrast agent

CytoTherapeutics and Cognetix collaborate on CNS R&D

Provir progresses through clinical trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...